Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation.
Eledon Pharmaceuticals stock last closed at $3.92, up 5.95% from the previous day, and has increased 41.01% in one year. It has overperformed other stocks in the Biotechnology industry by 1.13 percentage points. Eledon Pharmaceuticals stock is currently +190.37% from its 52-week low of $1.35, and -14.78% from its 52-week high of $4.60.
There are currently 77.19M shares of ELDN outstanding. The market capitalization of ELDN is $302.58M. In the past 24 hours, 2.64M ELDN shares were traded.
You need an online brokerage account to access the NASDAQ market and buy ELDN stock.
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you'll need to fill out some personal info so you are able to invest in ELDN stock today.
Now that you've finished signing up on one of the best stock market apps, you can securely and quickly fund your account:
Watch this video walkthrough for more details transferring funds into your brokerage account.
Once you have decided on the best place to buy Eledon Pharmaceuticals stock, it's crucial to research their stock prior to investing, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was created to help average investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on ELDN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge ELDN's intrinsic value.
Using relative valuations metrics:
You can do additional valuation analysis on ELDN's stock here.
You can dig deeper into what analysts are forecasting on the Eledon Pharmaceuticals stock forecast page.
In the past year, insiders at ELDN have not bought or sold any shares.
Research more about who owns ELDN shares here.
No, Eledon Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two primary order types:
Click the Open Trade button and your broker will place the order.
If you require additional help with buying stocks on eToro, click the how to video below:
Now that you own some ELDN stock, you'll want to stay up-to-date on your new investment.
Create a watchlist to see the latest developments about your ELDN stock.
To reiterate, here are the 6 steps to buy Eledon Pharmaceuticals stock:
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Eledon Pharmaceuticals, create a watchlist on WallStreetZen today.